These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22586233)

  • 1. Keeping patients safe while avoiding bias in randomised trials.
    Freemantle N; Van de Werf F
    BMJ; 2012 May; 344():e3297. PubMed ID: 22586233
    [No Abstract]   [Full Text] [Related]  

  • 2. The independent statistician for data monitoring committees.
    DeMets DL; Fleming TR
    Stat Med; 2004 May; 23(10):1513-7. PubMed ID: 15122729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical issues with the disclosure of surgical trial short-term data.
    Allardyce RA; Bagshaw PF; Frampton CM; Frizelle FA; Hewett PJ; Rieger NA; Smith JS; Solomon MJ; Stevenson AR
    ANZ J Surg; 2011 Mar; 81(3):125-31. PubMed ID: 21342382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous safety monitoring for randomized controlled clinical trials.
    Piller LB; Silverman MH; Ball G
    Contemp Clin Trials; 2011 Sep; 32 Suppl 1():S1. PubMed ID: 21458597
    [No Abstract]   [Full Text] [Related]  

  • 5. Data monitoring (and safety) committees--what are they and why do we need them? Primary Care Alliance for Clinical Trials (PACT) Network.
    Pirotta M; Chondros P;
    Aust Fam Physician; 2004 Nov; 33(11):950-1, 956. PubMed ID: 15584339
    [No Abstract]   [Full Text] [Related]  

  • 6. Design of randomized controlled trials.
    Stanley K
    Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Part 1: Ethical considerations.
    Ball G; Piller LB; Silverman MH
    Contemp Clin Trials; 2011 Sep; 32 Suppl 1():S2-4. PubMed ID: 21664987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bias in identifying and recruiting participants in cluster randomised trials: what can be done?
    Eldridge S; Kerry S; Torgerson DJ
    BMJ; 2009 Oct; 339():b4006. PubMed ID: 19819928
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing risk of bias in randomized controlled trials.
    Purgato M; Barbui C; Cipriani A
    Epidemiol Psichiatr Soc; 2010; 19(4):296-7. PubMed ID: 21322502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?
    Ellenberg SS; George SL
    Stat Med; 2004 May; 23(10):1503-5. PubMed ID: 15122727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of quality characteristics of randomised control trials published in dental journals.
    Pandis N; Polychronopoulou A; Eliades T
    J Dent; 2010 Sep; 38(9):713-21. PubMed ID: 20546823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striding forward or getting too big for their boots? The developing role of data monitoring committees in clinical trials.
    Tharmanathan P; Calvert MJ; Freemantle N
    J Clin Pharm Ther; 2006 Apr; 31(2):111-8. PubMed ID: 16635044
    [No Abstract]   [Full Text] [Related]  

  • 13. [Monitoring the safety of participants in randomised clinical trials: basis and methods].
    Tijssen JG
    Ned Tijdschr Geneeskd; 2008 Mar; 152(12):674-8. PubMed ID: 18438062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discussion of paper by Korn and Freidlin.
    Wittes J
    Am J Bioeth; 2011 Mar; 11(3):13-4. PubMed ID: 21400376
    [No Abstract]   [Full Text] [Related]  

  • 15. Methodological issues in randomized trials assessing probiotics for periodontal treatment.
    Dhingra K
    J Periodontal Res; 2012 Feb; 47(1):15-26. PubMed ID: 21777405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical issues arising when interim data in clinical trials is restricted to independent data monitoring committees.
    Wells RJ; Gartside PS; McHenry CL
    IRB; 2000 Jan; 22(1):7-11. PubMed ID: 12546010
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.
    Wittes J; Barrett-Connor E; Braunwald E; Chesney M; Cohen HJ; Demets D; Dunn L; Dwyer J; Heaney RP; Vogel V; Walters L; Yusuf S
    Clin Trials; 2007; 4(3):218-34. PubMed ID: 17715247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring clinical trials. Several points are contentious.
    Parry D
    BMJ; 2001 Dec; 323(7326):1425. PubMed ID: 11778590
    [No Abstract]   [Full Text] [Related]  

  • 19. Sources of bias in clinical trials.
    Pandis N
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):595-6. PubMed ID: 21967950
    [No Abstract]   [Full Text] [Related]  

  • 20. Interim analysis in randomized trials: DAMOCLES' sword?
    Besselink MG; van der Graaf Y; Gooszen HG
    J Clin Epidemiol; 2010 Apr; 63(4):353-4. PubMed ID: 19959333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.